Early Detection Starts With You: How One-Time Hereditary Cancer Testing Can Unlock a Lifetime of Personalized Screening

Webinar description: In this webinar, hear two powerful patient stories that illustrate the lifesaving impact of identifying hereditary cancer risk early and establishing a personalized, proactive screening strategy. These firsthand accounts vividly demonstrate how bringing genetic testing into routine primary care and OBGYN visits can help completely rewrite a patient’s health trajectory before cancer develops.

By the end of this webinar, you will be equipped to: 

  -  Recognize the critical role of primary care in identifying the millions of patients with

      increased hereditary cancer risk through routine family history intake

  -  Understand the holistic patient experience through real-world stories, examining the

      journey from testing and emotional

      impact to concrete health outcomes

  -  Confidently integrate guideline-backed hereditary cancer testing, ordering, and resulting

      into routine daily clinical workflows

  -  Understand Quest’s comprehensive support resources, from preauthorization and billing

      support to accessing on-demand clinical genetic counselors

  -  Apply post-test result management strategies to improve cancer screening compliance and

      improve patient outcomes

Time of talk: 59 minutes, 11 seconds

Presenter: 

  -  Kelly Tangney, MS, CGC, Board-certified Genetic Counselor, Director of Genetic Strategy &

     Solutions, Quest Diagnostics

  -  Bradely Hertz, Hereditary Cancer Previvor living with BRCA2

  -  Sara Kavanaugh, Hereditary Cancer Previvor & Advocate living with Lynch syndrome and

     Hereditary Breast Cancer Gene Mutation

Moderator:  Kelly Tangney, MS, CGC, Board-certified Genetic Counselor, Director of Genetic Strategy & Solutions, Quest

Recording Date:  October 1^st, 2026

Date published:  October 13^th, 2026

Keywords: Hereditary cancer, hereditary cancer testing, lynch syndrome, CHEK2, BRCA1, BRCA2, comprehensive panel, guideline-based panel

Disclosure: 

  -  The content was current as of the time of recording in 2026

  -  Kelly Tangney was employed by Quest Diagnostics at the time of the recording

Additional Resources

  -  Hereditary Cancer Testing Information: Single and multi-gene testing options with Quest diagnostics

  -  Podcast: Beyond BRCA: The bigger picture of hereditary breast cancer